1. Home
  2. ASRT vs CTMX Comparison

ASRT vs CTMX Comparison

Compare ASRT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • CTMX
  • Stock Information
  • Founded
  • ASRT 1995
  • CTMX 2008
  • Country
  • ASRT United States
  • CTMX United States
  • Employees
  • ASRT N/A
  • CTMX N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASRT Health Care
  • CTMX Health Care
  • Exchange
  • ASRT Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • ASRT 85.1M
  • CTMX 85.3M
  • IPO Year
  • ASRT 1997
  • CTMX 2015
  • Fundamental
  • Price
  • ASRT $0.80
  • CTMX $0.84
  • Analyst Decision
  • ASRT Strong Buy
  • CTMX Buy
  • Analyst Count
  • ASRT 4
  • CTMX 6
  • Target Price
  • ASRT $3.19
  • CTMX $5.77
  • AVG Volume (30 Days)
  • ASRT 362.1K
  • CTMX 947.0K
  • Earning Date
  • ASRT 03-10-2025
  • CTMX 03-10-2025
  • Dividend Yield
  • ASRT N/A
  • CTMX N/A
  • EPS Growth
  • ASRT N/A
  • CTMX N/A
  • EPS
  • ASRT N/A
  • CTMX 0.16
  • Revenue
  • ASRT $125,763,000.00
  • CTMX $126,617,000.00
  • Revenue This Year
  • ASRT N/A
  • CTMX $22.55
  • Revenue Next Year
  • ASRT $1.84
  • CTMX N/A
  • P/E Ratio
  • ASRT N/A
  • CTMX $5.23
  • Revenue Growth
  • ASRT N/A
  • CTMX 33.66
  • 52 Week Low
  • ASRT $0.73
  • CTMX $0.79
  • 52 Week High
  • ASRT $1.80
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 43.92
  • CTMX 45.15
  • Support Level
  • ASRT $0.78
  • CTMX $0.82
  • Resistance Level
  • ASRT $0.83
  • CTMX $0.98
  • Average True Range (ATR)
  • ASRT 0.03
  • CTMX 0.06
  • MACD
  • ASRT 0.00
  • CTMX 0.01
  • Stochastic Oscillator
  • ASRT 39.86
  • CTMX 33.58

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: